Coronavirus disease (COVID-19) has significantly impacted innumerable economies and posed a major challenge to the overall supply chain. It has tremendously affected the lives of people on account of stringent measures adopted by governing authorities of numerous countries to prevent the spread of the disease. These measures include closing state and interstate borders, imposing complete lockdowns and travel restrictions, shutting schools and colleges, and banning mass gatherings. Although it has brought sectors like aviation, entertainment, travel, and tourism to a sudden halt, it has positively influenced the health insurance sector worldwide. As per the estimate by IMARC Group, the global health insurance market size reached US$ 1,714.0 Billion in 2022. Looking forward, the market expected to reach US$ 2,599.8 Billion by 2028, exhibiting a growth rate (CAGR) of 7.11% during 2023-2028.
According to the International Diabetes Federation (IDF), COVID-19 can become life-threatening for people with low immunity, cancer, diabetes, asthma, and other pre-existing medical conditions. The disease has already affected more than 140 million people and taken 3 million lives across the globe. It has also resulted in a considerable rise in the demand for health insurance as people want to ensure the best medical treatments are provided to them and their family members.
Standard health insurance covers pre, post-, and in-hospitalization expenses of several chronic diseases. On the other hand, COVID-19 health insurance offers coverage to people who are diagnosed with the disease. It does not cater coverage for any other disease. At present, governing authorities of numerous countries are bearing the cost of check-ups as well as pre-hospitalization procedures.
Keeping in mind the health and financial crises of people, health insurance providers are preparing themselves for an increase in health products-related queries and a delay in the renewals of existing policies on account of the paucity of funds in the hands of policyholders. These providers are focusing on making customized plans to ensure coverage of the affected. They are introducing plans that offer coverage irrespective of travel or medical history. Besides this, as there is an uptake in digital health products, insurers are resorting to paperless app/web-based seamless processes to increase productivity and cost-efficiency.
Telemedicine refers to the delivery of healthcare services wherein distance is a critical factor. It involves the utilization of information and communications technology (ICT) by patients and healthcare professionals for the exchange of valid information. This information includes diagnosis, treatment, and prevention of disease and injuries, and research and evaluation. With the growing preferences for telemedicine to prevent the spread of the disease, health insurance providers are offering telemedicine consultation coverage in health insurance to expand their existing consumer base.
Suggested reading: Impact of COVID-19 on Global Digital Health Industry
To maintain an upper hand over other competitors, health insurers nowadays are focusing on mitigating some of the financial risks by following these strategies:
Discover opportunities, challenges, and trends in the Health Insurance industry with IMARC’s market research report. Try a free sample today!
Phone: +1-631-791-1145
Phone: +91-120-433-0800
Phone: +44-753-714-6104
Email: sales@imarcgroup.com
134 N 4th St. Brooklyn, NY 11249, USA
+1-631-791-1145
Level II & III, B-70, Sector 2, Noida, Uttar Pradesh 201301, India
+91-120-433-0800
30 Churchill Place London E14 5EU, UK
+44-753-714-6104
© Copyright IMARC Services Private Limited 2024. All rights reserved. Terms & Conditions | Privacy Policy | SiteMap